Latest News of PYXS
Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green
By Yahoo! Finance |
5 months ago
Ownership research and analyst forecasts provide insights into stock opportunities. Pyxis Oncology, Inc. (NASDAQ: PYXS) is primarily owned by institutions, with key shareholders like Pfizer Inc. and h...